Introduction  ||| S:24 E:45 ||| NN
For  ||| S:45 E:49 ||| IN
many  ||| S:49 E:54 ||| JJ
years ||| S:54 E:59 ||| NNS
,  ||| S:59 E:61 ||| ,
scientists  ||| S:61 E:72 ||| NNS
believed  ||| S:72 E:81 ||| VBD
that  ||| S:81 E:86 ||| DT
point  ||| S:86 E:92 ||| NN
mutations  ||| S:92 E:110 ||| NNS
in  ||| S:110 E:113 ||| IN
genes  ||| S:113 E:119 ||| NNS
are  ||| S:119 E:123 ||| VBP
the  ||| S:123 E:127 ||| DT
genetic  ||| S:127 E:135 ||| JJ
switches  ||| S:135 E:144 ||| NNS
for  ||| S:144 E:148 ||| IN
somatic  ||| S:148 E:156 ||| NN
and  ||| S:156 E:160 ||| CC
inherited  ||| S:160 E:178 ||| JJ
diseases  ||| S:178 E:187 ||| NNS
such  ||| S:187 E:192 ||| JJ
as  ||| S:192 E:195 ||| IN
cystic  ||| S:195 E:202 ||| JJ
fibrosis ||| S:202 E:210 ||| NN
,  ||| S:210 E:212 ||| ,
phenylketonuria  ||| S:212 E:228 ||| NN
and  ||| S:228 E:240 ||| CC
cancer ||| S:240 E:246 ||| NN
.  ||| S:246 E:248 ||| .
For  ||| S:248 E:252 ||| IN
this  ||| S:252 E:257 ||| DT
to  ||| S:257 E:260 ||| TO
be  ||| S:260 E:263 ||| VB
the  ||| S:263 E:267 ||| DT
case ||| S:267 E:271 ||| NN
,  ||| S:271 E:273 ||| ,
disease-associated  ||| S:273 E:292 ||| JJ
amino  ||| S:292 E:306 ||| JJ
acid  ||| S:306 E:311 ||| NN
substitutions  ||| S:311 E:325 ||| NNS
should  ||| S:325 E:332 ||| MD
occur  ||| S:332 E:338 ||| VB
in  ||| S:338 E:341 ||| IN
functionally  ||| S:341 E:354 ||| JJ
important  ||| S:354 E:372 ||| JJ
regions  ||| S:372 E:380 ||| NNS
of  ||| S:380 E:383 ||| IN
the  ||| S:383 E:387 ||| DT
protein  ||| S:387 E:395 ||| NN
products  ||| S:395 E:404 ||| NNS
of  ||| S:404 E:407 ||| IN
genes ||| S:407 E:412 ||| NNS
.  ||| S:412 E:414 ||| .
While  ||| S:414 E:420 ||| IN
it  ||| S:420 E:423 ||| PRP
has  ||| S:423 E:427 ||| VBZ
been  ||| S:427 E:440 ||| VBN
shown  ||| S:440 E:446 ||| VBN
in  ||| S:446 E:449 ||| IN
specific  ||| S:449 E:458 ||| JJ
cases  ||| S:458 E:464 ||| NNS
that  ||| S:464 E:469 ||| IN
disease-associated  ||| S:469 E:488 ||| JJ
amino  ||| S:488 E:494 ||| JJ
acid  ||| S:494 E:507 ||| NN
substitutions  ||| S:507 E:521 ||| NNS
affect  ||| S:521 E:528 ||| VBP
protein  ||| S:528 E:536 ||| JJ
function ||| S:536 E:544 ||| NN
,  ||| S:544 E:546 ||| ,
until  ||| S:546 E:552 ||| IN
now  ||| S:552 E:556 ||| RB
few  ||| S:556 E:568 ||| JJ
studies  ||| S:568 E:576 ||| NNS
have  ||| S:576 E:581 ||| VBP
examined  ||| S:581 E:590 ||| VBN
this  ||| S:590 E:595 ||| DT
across  ||| S:595 E:602 ||| IN
many  ||| S:602 E:607 ||| JJ
genes ||| S:607 E:612 ||| NNS
.  ||| S:612 E:614 ||| .
Here  ||| S:614 E:619 ||| RB
we  ||| S:619 E:630 ||| PRP
provide  ||| S:630 E:638 ||| VBP
direct  ||| S:638 E:645 ||| JJ
evidence  ||| S:645 E:654 ||| NN
that  ||| S:654 E:659 ||| IN
disease-associated  ||| S:659 E:678 ||| JJ
point  ||| S:678 E:692 ||| NN
mutations  ||| S:692 E:702 ||| NNS
occur  ||| S:702 E:708 ||| VBP
in  ||| S:708 E:711 ||| IN
functionally  ||| S:711 E:724 ||| JJ
important  ||| S:724 E:734 ||| JJ
regions  ||| S:734 E:742 ||| NNS
of  ||| S:742 E:745 ||| IN
the  ||| S:745 E:757 ||| DT
genome  ||| S:757 E:764 ||| NN
and  ||| S:764 E:768 ||| CC
are  ||| S:768 E:772 ||| VBP
not  ||| S:772 E:776 ||| RB
distributed  ||| S:776 E:788 ||| VBN
equally  ||| S:788 E:796 ||| RB
across  ||| S:796 E:803 ||| IN
the  ||| S:803 E:807 ||| DT
coding  ||| S:807 E:822 ||| JJ
regions  ||| S:822 E:830 ||| NNS
of  ||| S:830 E:833 ||| IN
genes ||| S:833 E:838 ||| NNS
.  ||| S:838 E:840 ||| .
This  ||| S:840 E:845 ||| DT
work  ||| S:845 E:850 ||| NN
supports  ||| S:850 E:859 ||| VBZ
recent  ||| S:859 E:866 ||| JJ
efforts  ||| S:866 E:874 ||| NNS
to  ||| S:874 E:885 ||| TO
collect  ||| S:885 E:893 ||| VB
disease  ||| S:893 E:901 ||| NN
associated  ||| S:901 E:912 ||| VBN
mutational  ||| S:912 E:923 ||| JJ
data  ||| S:923 E:928 ||| NNS
in  ||| S:928 E:931 ||| IN
databases  ||| S:931 E:941 ||| NN
and  ||| S:941 E:953 ||| CC
suggests  ||| S:953 E:962 ||| VBZ
that  ||| S:962 E:967 ||| DT
many  ||| S:967 E:972 ||| JJ
of  ||| S:972 E:975 ||| IN
the  ||| S:975 E:979 ||| DT
mutations  ||| S:979 E:989 ||| NN
represented  ||| S:989 E:1001 ||| VBD
in  ||| S:1001 E:1004 ||| IN
those  ||| S:1004 E:1018 ||| DT
databases  ||| S:1018 E:1028 ||| NNS
are  ||| S:1028 E:1032 ||| VBP
the  ||| S:1032 E:1036 ||| DT
likely  ||| S:1036 E:1043 ||| JJ
underlying  ||| S:1043 E:1054 ||| JJ
molecular  ||| S:1054 E:1064 ||| JJ
cause  ||| S:1064 E:1070 ||| NN
of  ||| S:1070 E:1081 ||| IN
disease ||| S:1081 E:1088 ||| NN
.  ||| S:1088 E:1098 ||| .
Recently  ||| S:1098 E:1107 ||| RB
there  ||| S:1107 E:1113 ||| EX
have  ||| S:1113 E:1118 ||| VBP
been  ||| S:1118 E:1123 ||| VBN
a  ||| S:1123 E:1125 ||| DT
number  ||| S:1125 E:1132 ||| NN
of  ||| S:1132 E:1135 ||| IN
commercial  ||| S:1135 E:1146 ||| JJ
and  ||| S:1146 E:1158 ||| CC
public  ||| S:1158 E:1165 ||| JJ
projects  ||| S:1165 E:1174 ||| NNS
aimed  ||| S:1174 E:1180 ||| VBN
at  ||| S:1180 E:1183 ||| IN
collecting  ||| S:1183 E:1194 ||| VBG
and  ||| S:1194 E:1198 ||| CC
understanding  ||| S:1198 E:1212 ||| VBG
human  ||| S:1212 E:1226 ||| JJ
genomic  ||| S:1226 E:1234 ||| JJ
variation  ||| S:1234 E:1244 ||| NN
[  ||| S:1244 E:1246 ||| -LRB-
1  ||| S:1246 E:1248 ||| LS
]  ||| S:1248 E:1250 ||| -RRB-
.  ||| S:1250 E:1252 ||| .
The  ||| S:1252 E:1256 ||| DT
goal  ||| S:1256 E:1261 ||| NN
of  ||| S:1261 E:1264 ||| IN
these  ||| S:1264 E:1270 ||| DT
projects  ||| S:1270 E:1279 ||| NNS
is  ||| S:1279 E:1282 ||| VBZ
to  ||| S:1282 E:1293 ||| TO
provide  ||| S:1293 E:1301 ||| VB
an  ||| S:1301 E:1304 ||| DT
understanding  ||| S:1304 E:1318 ||| NN
of  ||| S:1318 E:1321 ||| IN
how  ||| S:1321 E:1325 ||| WRB
genotype  ||| S:1325 E:1334 ||| NN
is  ||| S:1334 E:1337 ||| VBZ
associated  ||| S:1337 E:1348 ||| VBN
with  ||| S:1348 E:1361 ||| IN
disease ||| S:1361 E:1368 ||| NN
,  ||| S:1368 E:1370 ||| ,
how  ||| S:1370 E:1374 ||| WRB
it  ||| S:1374 E:1377 ||| PRP
affects  ||| S:1377 E:1385 ||| VBZ
our  ||| S:1385 E:1389 ||| PRP$
response  ||| S:1389 E:1398 ||| NN
to  ||| S:1398 E:1401 ||| TO
drugs  ||| S:1401 E:1407 ||| NNS
and  ||| S:1407 E:1411 ||| CC
how  ||| S:1411 E:1415 ||| WRB
it  ||| S:1415 E:1426 ||| PRP
affects  ||| S:1426 E:1434 ||| VBZ
the  ||| S:1434 E:1438 ||| DT
protein  ||| S:1438 E:1446 ||| NN
products  ||| S:1446 E:1455 ||| NNS
of  ||| S:1455 E:1458 ||| IN
genes ||| S:1458 E:1463 ||| NNS
.  ||| S:1463 E:1465 ||| .
Examples  ||| S:1465 E:1474 ||| NNS
of  ||| S:1474 E:1477 ||| IN
these  ||| S:1477 E:1491 ||| DT
projects  ||| S:1491 E:1500 ||| NNS
include  ||| S:1500 E:1508 ||| VBP
the  ||| S:1508 E:1512 ||| DT
SNP  ||| S:1512 E:1516 ||| NNP
Consortium ||| S:1516 E:1526 ||| NNP
,  ||| S:1526 E:1528 ||| ,
the  ||| S:1528 E:1532 ||| DT
Human  ||| S:1532 E:1538 ||| NNP
Genome  ||| S:1538 E:1553 ||| NNP
Mutation  ||| S:1553 E:1562 ||| NNP
Database  ||| S:1562 E:1571 ||| NNP
[  ||| S:1571 E:1573 ||| -LRB-
2  ||| S:1573 E:1575 ||| LS
]  ||| S:1575 E:1577 ||| -RRB-
,  ||| S:1577 E:1579 ||| ,
many  ||| S:1579 E:1584 ||| JJ
gene  ||| S:1584 E:1589 ||| NN
specific  ||| S:1589 E:1598 ||| JJ
databases  ||| S:1598 E:1608 ||| NNS
(  ||| S:1608 E:1610 ||| -LRB-
[  ||| S:1610 E:1620 ||| CD
3  ||| S:1620 E:1622 ||| CD
4  ||| S:1622 E:1624 ||| CD
]  ||| S:1624 E:1626 ||| -RRB-
,  ||| S:1626 E:1628 ||| ,
for  ||| S:1628 E:1632 ||| IN
example ||| S:1632 E:1639 ||| NN
) ||| S:1639 E:1640 ||| -RRB-
,  ||| S:1640 E:1642 ||| ,
and  ||| S:1642 E:1646 ||| CC
both  ||| S:1646 E:1651 ||| DT
public  ||| S:1651 E:1658 ||| JJ
and  ||| S:1658 E:1662 ||| CC
private  ||| S:1662 E:1670 ||| JJ
genome  ||| S:1670 E:1685 ||| JJ
sequencing  ||| S:1685 E:1696 ||| JJ
efforts  ||| S:1696 E:1704 ||| NNS
[  ||| S:1704 E:1706 ||| -LRB-
5  ||| S:1706 E:1708 ||| LS
]  ||| S:1708 E:1710 ||| -RRB-
.  ||| S:1710 E:1712 ||| .
Much  ||| S:1712 E:1717 ||| RB
of  ||| S:1717 E:1720 ||| IN
the  ||| S:1720 E:1724 ||| DT
data  ||| S:1724 E:1729 ||| NNS
that  ||| S:1729 E:1734 ||| WDT
is  ||| S:1734 E:1737 ||| VBZ
being  ||| S:1737 E:1751 ||| VBG
collected  ||| S:1751 E:1761 ||| NNS
are  ||| S:1761 E:1765 ||| VBP
mutations  ||| S:1765 E:1775 ||| JJ
annotated  ||| S:1775 E:1785 ||| NN
with  ||| S:1785 E:1790 ||| IN
their  ||| S:1790 E:1796 ||| PRP$
observed  ||| S:1796 E:1813 ||| JJ
phenotype ||| S:1813 E:1822 ||| NN
.  ||| S:1822 E:1824 ||| .
Automated  ||| S:1824 E:1834 ||| JJ
annotation  ||| S:1834 E:1845 ||| JJ
methods  ||| S:1845 E:1853 ||| NNS
based  ||| S:1853 E:1859 ||| VBN
on  ||| S:1859 E:1862 ||| IN
structural  ||| S:1862 E:1881 ||| JJ
and  ||| S:1881 E:1885 ||| CC
evolutionary  ||| S:1885 E:1898 ||| JJ
parameters  ||| S:1898 E:1909 ||| NNS
can  ||| S:1909 E:1913 ||| MD
lead  ||| S:1913 E:1918 ||| VB
to  ||| S:1918 E:1921 ||| TO
insight  ||| S:1921 E:1929 ||| VB
into  ||| S:1929 E:1934 ||| IN
the  ||| S:1934 E:1946 ||| DT
molecular  ||| S:1946 E:1956 ||| JJ
basis  ||| S:1956 E:1962 ||| NN
of  ||| S:1962 E:1965 ||| IN
disease ||| S:1965 E:1972 ||| NN
.  ||| S:1972 E:1982 ||| .
With  ||| S:1982 E:1987 ||| IN
more  ||| S:1987 E:1992 ||| JJR
than  ||| S:1992 E:1997 ||| IN
4,000,000  ||| S:1997 E:2007 ||| NNP
identified  ||| S:2007 E:2018 ||| VBD
variations  ||| S:2018 E:2029 ||| NNS
and  ||| S:2029 E:2033 ||| CC
with  ||| S:2033 E:2046 ||| IN
over  ||| S:2046 E:2051 ||| IN
20,000  ||| S:2051 E:2058 ||| CD
of  ||| S:2058 E:2061 ||| IN
them  ||| S:2061 E:2066 ||| PRP
annotated  ||| S:2066 E:2076 ||| VBD
with  ||| S:2076 E:2081 ||| IN
a  ||| S:2081 E:2083 ||| DT
phenotype ||| S:2083 E:2092 ||| NN
,  ||| S:2092 E:2094 ||| ,
we  ||| S:2094 E:2097 ||| PRP
are  ||| S:2097 E:2109 ||| VBP
facing  ||| S:2109 E:2116 ||| VBG
the  ||| S:2116 E:2120 ||| DT
problem  ||| S:2120 E:2128 ||| NN
of  ||| S:2128 E:2131 ||| IN
having  ||| S:2131 E:2138 ||| VBG
many  ||| S:2138 E:2143 ||| JJ
uncharacterized  ||| S:2143 E:2167 ||| JJ
mutations ||| S:2167 E:2176 ||| NNS
.  ||| S:2176 E:2178 ||| .
Algorithms  ||| S:2178 E:2189 ||| NNS
are  ||| S:2189 E:2193 ||| VBP
needed  ||| S:2193 E:2200 ||| VBN
for  ||| S:2200 E:2204 ||| IN
automatically  ||| S:2204 E:2226 ||| RB
annotating  ||| S:2226 E:2237 ||| VB
these  ||| S:2237 E:2243 ||| DT
gene  ||| S:2243 E:2248 ||| NN
variations  ||| S:2248 E:2259 ||| NNS
to  ||| S:2259 E:2262 ||| TO
gain  ||| S:2262 E:2267 ||| VB
insight  ||| S:2267 E:2275 ||| VBN
into  ||| S:2275 E:2280 ||| IN
how  ||| S:2280 E:2292 ||| WRB
they  ||| S:2292 E:2297 ||| PRP
affect  ||| S:2297 E:2304 ||| VBP
the  ||| S:2304 E:2308 ||| DT
gene ||| S:2308 E:2312 ||| NN
's  ||| S:2312 E:2315 ||| POS
regulation  ||| S:2315 E:2326 ||| NN
and ||| S:2326 E:2329 ||| CC
/ ||| S:2329 E:2330 ||| NNP
or  ||| S:2330 E:2333 ||| CC
function  ||| S:2333 E:2342 ||| NN
of  ||| S:2342 E:2345 ||| IN
its  ||| S:2345 E:2357 ||| PRP$
protein  ||| S:2357 E:2365 ||| NN
products ||| S:2365 E:2373 ||| NNS
.  ||| S:2373 E:2375 ||| .
Using  ||| S:2375 E:2381 ||| VBG
many  ||| S:2381 E:2386 ||| JJ
collection  ||| S:2386 E:2397 ||| NN
technologies ||| S:2397 E:2409 ||| NNS
,  ||| S:2409 E:2419 ||| ,
uncharacterized  ||| S:2419 E:2435 ||| VBG
SNP  ||| S:2435 E:2439 ||| NNP
data  ||| S:2439 E:2444 ||| NN
is  ||| S:2444 E:2447 ||| VBZ
being  ||| S:2447 E:2453 ||| VBG
placed  ||| S:2453 E:2460 ||| VBN
in  ||| S:2460 E:2463 ||| IN
public  ||| S:2463 E:2478 ||| JJ
databases  ||| S:2478 E:2488 ||| JJ
such  ||| S:2488 E:2493 ||| JJ
as  ||| S:2493 E:2496 ||| IN
the  ||| S:2496 E:2500 ||| DT
Human  ||| S:2500 E:2506 ||| NNP
Genome  ||| S:2506 E:2513 ||| NNP
Mutation  ||| S:2513 E:2522 ||| NNP
Database  ||| S:2522 E:2531 ||| NNP
( ||| S:2531 E:2532 ||| -LRB-
over  ||| S:2532 E:2545 ||| IN
20,000  ||| S:2545 E:2552 ||| CD
entries ||| S:2552 E:2559 ||| NNS
)  ||| S:2559 E:2561 ||| -RRB-
[  ||| S:2561 E:2563 ||| -LRB-
2  ||| S:2563 E:2565 ||| LS
]  ||| S:2565 E:2567 ||| -RRB-
and  ||| S:2567 E:2571 ||| CC
the  ||| S:2571 E:2575 ||| DT
National  ||| S:2575 E:2584 ||| NNP
Cancer  ||| S:2584 E:2591 ||| NNP
Institute ||| S:2591 E:2600 ||| NNP
's  ||| S:2600 E:2611 ||| POS
CGAP-GAI  ||| S:2611 E:2620 ||| JJ
( ||| S:2620 E:2621 ||| -LRB-
Cancer  ||| S:2621 E:2628 ||| NNP
Genome  ||| S:2628 E:2635 ||| NNP
Anatomy  ||| S:2635 E:2643 ||| NNP
Project  ||| S:2643 E:2651 ||| NNP
Genetic  ||| S:2651 E:2659 ||| NNP
Annotation  ||| S:2659 E:2678 ||| NNP
Initiative ||| S:2678 E:2688 ||| NNP
)  ||| S:2688 E:2690 ||| -RRB-
[  ||| S:2690 E:2692 ||| -LRB-
6  ||| S:2692 E:2694 ||| CD
]  ||| S:2694 E:2696 ||| -RRB-
.  ||| S:2696 E:2698 ||| .
The  ||| S:2698 E:2702 ||| DT
CGAP-GAI  ||| S:2702 E:2711 ||| JJ
group  ||| S:2711 E:2717 ||| NN
has  ||| S:2717 E:2721 ||| VBZ
identified  ||| S:2721 E:2740 ||| VBN
10,243  ||| S:2740 E:2747 ||| CD
SNPs  ||| S:2747 E:2752 ||| NN
by  ||| S:2752 E:2755 ||| IN
examining  ||| S:2755 E:2765 ||| VBG
publicly  ||| S:2765 E:2774 ||| RB
available  ||| S:2774 E:2784 ||| JJ
EST  ||| S:2784 E:2788 ||| NNP
( ||| S:2788 E:2789 ||| -LRB-
Expressed  ||| S:2789 E:2807 ||| NNP
Sequence  ||| S:2807 E:2816 ||| NNP
Tag ||| S:2816 E:2819 ||| NNP
)  ||| S:2819 E:2821 ||| -RRB-
chromatograms ||| S:2821 E:2834 ||| NN
.  ||| S:2834 E:2844 ||| .
Software  ||| S:2844 E:2853 ||| NN
for  ||| S:2853 E:2857 ||| IN
analyzing  ||| S:2857 E:2867 ||| VBG
unannotated  ||| S:2867 E:2879 ||| JJ
SNPs  ||| S:2879 E:2884 ||| NN
in  ||| S:2884 E:2887 ||| IN
known  ||| S:2887 E:2893 ||| JJ
disease  ||| S:2893 E:2909 ||| NN
associated  ||| S:2909 E:2920 ||| VBN
genes  ||| S:2920 E:2926 ||| NNS
will  ||| S:2926 E:2931 ||| MD
be  ||| S:2931 E:2934 ||| VB
especially  ||| S:2934 E:2945 ||| RB
useful  ||| S:2945 E:2952 ||| JJ
when  ||| S:2952 E:2957 ||| WRB
previously  ||| S:2957 E:2976 ||| RB
unobserved  ||| S:2976 E:2987 ||| JJ
mutations  ||| S:2987 E:2997 ||| NNS
are  ||| S:2997 E:3001 ||| VBP
discovered ||| S:3001 E:3011 ||| VBN
.  ||| S:3011 E:3013 ||| .
Every  ||| S:3013 E:3019 ||| DT
human  ||| S:3019 E:3025 ||| NN
has  ||| S:3025 E:3037 ||| VBZ
genotypic  ||| S:3037 E:3047 ||| JJ
differences  ||| S:3047 E:3059 ||| NNS
from  ||| S:3059 E:3064 ||| IN
the  ||| S:3064 E:3068 ||| DT
standard  ||| S:3068 E:3077 ||| JJ
genome  ||| S:3077 E:3092 ||| NNS
approximately  ||| S:3092 E:3106 ||| RB
every  ||| S:3106 E:3112 ||| DT
thousand  ||| S:3112 E:3121 ||| CD
base  ||| S:3121 E:3126 ||| NN
pairs  ||| S:3126 E:3132 ||| NNS
[  ||| S:3132 E:3134 ||| -LRB-
7  ||| S:3134 E:3136 ||| CD
8  ||| S:3136 E:3138 ||| CD
9  ||| S:3138 E:3140 ||| CD
]  ||| S:3140 E:3142 ||| -RRB-
.  ||| S:3142 E:3144 ||| .
Given  ||| S:3144 E:3158 ||| VBN
knowledge  ||| S:3158 E:3168 ||| NN
of  ||| S:3168 E:3171 ||| IN
how  ||| S:3171 E:3175 ||| WRB
a  ||| S:3175 E:3177 ||| DT
genotype  ||| S:3177 E:3186 ||| JJ
differs  ||| S:3186 E:3194 ||| NN
from  ||| S:3194 E:3199 ||| IN
the  ||| S:3199 E:3203 ||| DT
standard ||| S:3203 E:3211 ||| NN
,  ||| S:3211 E:3213 ||| ,
it  ||| S:3213 E:3224 ||| PRP
is  ||| S:3224 E:3227 ||| VBZ
important  ||| S:3227 E:3237 ||| JJ
to  ||| S:3237 E:3240 ||| TO
be  ||| S:3240 E:3243 ||| VB
able  ||| S:3243 E:3248 ||| JJ
to  ||| S:3248 E:3251 ||| TO
predict  ||| S:3251 E:3259 ||| VB
which  ||| S:3259 E:3265 ||| WDT
of  ||| S:3265 E:3268 ||| IN
the  ||| S:3268 E:3272 ||| DT
variations  ||| S:3272 E:3291 ||| NNS
are  ||| S:3291 E:3295 ||| VBP
likely  ||| S:3295 E:3302 ||| JJ
to  ||| S:3302 E:3305 ||| TO
be  ||| S:3305 E:3308 ||| VB
the  ||| S:3308 E:3312 ||| DT
cause  ||| S:3312 E:3318 ||| NN
of  ||| S:3318 E:3321 ||| IN
disease  ||| S:3321 E:3329 ||| NN
or  ||| S:3329 E:3332 ||| CC
other  ||| S:3332 E:3338 ||| JJ
phenotypic  ||| S:3338 E:3357 ||| JJ
differences ||| S:3357 E:3368 ||| NNS
.  ||| S:3368 E:3370 ||| .
Evolutionary  ||| S:3370 E:3383 ||| JJ
information  ||| S:3383 E:3395 ||| NN
about  ||| S:3395 E:3401 ||| IN
regulatory  ||| S:3401 E:3412 ||| JJ
and  ||| S:3412 E:3424 ||| CC
coding  ||| S:3424 E:3431 ||| JJ
regions  ||| S:3431 E:3439 ||| NNS
of  ||| S:3439 E:3442 ||| IN
genes  ||| S:3442 E:3448 ||| NNS
can  ||| S:3448 E:3452 ||| MD
be  ||| S:3452 E:3455 ||| VB
used  ||| S:3455 E:3460 ||| VBN
to  ||| S:3460 E:3463 ||| TO
highlight  ||| S:3463 E:3473 ||| VB
certain  ||| S:3473 E:3489 ||| JJ
mutations  ||| S:3489 E:3499 ||| NNS
or  ||| S:3499 E:3502 ||| CC
groups  ||| S:3502 E:3509 ||| NNS
of  ||| S:3509 E:3512 ||| IN
mutations  ||| S:3512 E:3522 ||| NNS
that  ||| S:3522 E:3527 ||| WDT
are  ||| S:3527 E:3531 ||| VBP
attributable  ||| S:3531 E:3544 ||| JJ
to  ||| S:3544 E:3547 ||| TO
a  ||| S:3547 E:3557 ||| DT
phenotype  ||| S:3557 E:3567 ||| NN
[  ||| S:3567 E:3569 ||| -LRB-
10  ||| S:3569 E:3572 ||| CD
11  ||| S:3572 E:3575 ||| CD
12  ||| S:3575 E:3578 ||| CD
]  ||| S:3578 E:3580 ||| -RRB-
.  ||| S:3580 E:3590 ||| .
Early  ||| S:3590 E:3596 ||| JJ
tools  ||| S:3596 E:3602 ||| NNS
using  ||| S:3602 E:3608 ||| VBG
phylogenetic  ||| S:3608 E:3621 ||| NNS
and  ||| S:3621 E:3625 ||| CC
structural  ||| S:3625 E:3644 ||| JJ
information  ||| S:3644 E:3656 ||| NN
have  ||| S:3656 E:3661 ||| VBP
shown  ||| S:3661 E:3667 ||| VBN
promise  ||| S:3667 E:3675 ||| NN
in  ||| S:3675 E:3678 ||| IN
predicting  ||| S:3678 E:3689 ||| VBG
the  ||| S:3689 E:3693 ||| DT
functional  ||| S:3693 E:3712 ||| JJ
consequences  ||| S:3712 E:3725 ||| NNS
of  ||| S:3725 E:3728 ||| IN
a  ||| S:3728 E:3730 ||| DT
mutation  ||| S:3730 E:3739 ||| NN
[  ||| S:3739 E:3741 ||| -LRB-
13  ||| S:3741 E:3744 ||| CD
]  ||| S:3744 E:3746 ||| -RRB-
.  ||| S:3746 E:3748 ||| .
These  ||| S:3748 E:3754 ||| DT
reports  ||| S:3754 E:3762 ||| NNS
predict  ||| S:3762 E:3778 ||| VBP
that  ||| S:3778 E:3783 ||| IN
anywhere  ||| S:3783 E:3792 ||| RB
between  ||| S:3792 E:3800 ||| IN
20-36 ||| S:3800 E:3805 ||| CD
%  ||| S:3805 E:3807 ||| NN
of  ||| S:3807 E:3810 ||| IN
non-synonymous  ||| S:3810 E:3825 ||| JJ
SNPs  ||| S:3825 E:3830 ||| NNS
alter  ||| S:3830 E:3844 ||| VBP
the  ||| S:3844 E:3848 ||| DT
function  ||| S:3848 E:3857 ||| NN
of  ||| S:3857 E:3860 ||| IN
a  ||| S:3860 E:3862 ||| DT
gene ||| S:3862 E:3866 ||| NN
's  ||| S:3866 E:3869 ||| POS
protein  ||| S:3869 E:3877 ||| NN
product ||| S:3877 E:3884 ||| NN
.  ||| S:3884 E:3886 ||| .
In  ||| S:3886 E:3889 ||| IN
the  ||| S:3889 E:3893 ||| DT
report  ||| S:3893 E:3900 ||| NN
by  ||| S:3900 E:3911 ||| IN
Chasman  ||| S:3911 E:3919 ||| NNP
and  ||| S:3919 E:3923 ||| CC
Adams ||| S:3923 E:3928 ||| NNP
,  ||| S:3928 E:3930 ||| ,
evolutionary  ||| S:3930 E:3943 ||| JJ
information  ||| S:3943 E:3955 ||| NN
was  ||| S:3955 E:3959 ||| VBD
predicted  ||| S:3959 E:3977 ||| VBN
to  ||| S:3977 E:3980 ||| TO
be  ||| S:3980 E:3983 ||| VB
a  ||| S:3983 E:3985 ||| DT
useful  ||| S:3985 E:3992 ||| JJ
component  ||| S:3992 E:4002 ||| NN
in  ||| S:4002 E:4005 ||| IN
determining  ||| S:4005 E:4017 ||| VBG
whether  ||| S:4017 E:4025 ||| IN
a  ||| S:4025 E:4027 ||| DT
mutation  ||| S:4027 E:4044 ||| NN
is  ||| S:4044 E:4047 ||| VBZ
deleterious  ||| S:4047 E:4059 ||| JJ
[  ||| S:4059 E:4061 ||| -LRB-
13  ||| S:4061 E:4064 ||| CD
14  ||| S:4064 E:4067 ||| CD
]  ||| S:4067 E:4069 ||| -RRB-
.  ||| S:4069 E:4071 ||| .
Disease  ||| S:4071 E:4079 ||| NN
causing  ||| S:4079 E:4087 ||| VBG
mutations  ||| S:4087 E:4097 ||| NNS
are  ||| S:4097 E:4109 ||| VBP
also  ||| S:4109 E:4114 ||| RB
likely  ||| S:4114 E:4121 ||| JJ
structurally  ||| S:4121 E:4134 ||| JJ
perturbing  ||| S:4134 E:4145 ||| NN
at  ||| S:4145 E:4148 ||| IN
the  ||| S:4148 E:4152 ||| DT
protein  ||| S:4152 E:4160 ||| NN
level  ||| S:4160 E:4166 ||| NN
[  ||| S:4166 E:4176 ||| -LRB-
15  ||| S:4176 E:4179 ||| CD
]  ||| S:4179 E:4181 ||| -RRB-
.  ||| S:4181 E:4183 ||| .
Ng  ||| S:4183 E:4186 ||| NNP
and  ||| S:4186 E:4190 ||| CC
Henikoff  ||| S:4190 E:4199 ||| NNP
have  ||| S:4199 E:4204 ||| VBP
introduced  ||| S:4204 E:4215 ||| VBN
SIFT ||| S:4215 E:4219 ||| NNP
,  ||| S:4219 E:4221 ||| ,
a  ||| S:4221 E:4223 ||| DT
method  ||| S:4223 E:4230 ||| NN
for  ||| S:4230 E:4242 ||| IN
predicting  ||| S:4242 E:4253 ||| VBG
functional  ||| S:4253 E:4264 ||| JJ
SNPs  ||| S:4264 E:4269 ||| NN
from  ||| S:4269 E:4274 ||| IN
a  ||| S:4274 E:4276 ||| DT
database  ||| S:4276 E:4285 ||| NN
of  ||| S:4285 E:4288 ||| IN
unannotated  ||| S:4288 E:4308 ||| JJ
polymorphisms  ||| S:4308 E:4322 ||| NNS
[  ||| S:4322 E:4324 ||| -LRB-
16  ||| S:4324 E:4327 ||| CD
17  ||| S:4327 E:4330 ||| CD
]  ||| S:4330 E:4332 ||| -RRB-
.  ||| S:4332 E:4342 ||| .
The  ||| S:4342 E:4346 ||| DT
relationship  ||| S:4346 E:4359 ||| NN
between  ||| S:4359 E:4367 ||| IN
disease-associated  ||| S:4367 E:4386 ||| JJ
mutation  ||| S:4386 E:4403 ||| NN
positions  ||| S:4403 E:4413 ||| NNS
and  ||| S:4413 E:4417 ||| CC
evolutionary  ||| S:4417 E:4430 ||| JJ
conservation  ||| S:4430 E:4443 ||| NN
has  ||| S:4443 E:4447 ||| VBZ
been  ||| S:4447 E:4452 ||| VBN
reported  ||| S:4452 E:4469 ||| VBN
in  ||| S:4469 E:4472 ||| IN
specific  ||| S:4472 E:4481 ||| JJ
cases ||| S:4481 E:4486 ||| NNS
.  ||| S:4486 E:4488 ||| .
An  ||| S:4488 E:4491 ||| DT
analysis  ||| S:4491 E:4500 ||| NN
of  ||| S:4500 E:4503 ||| IN
the  ||| S:4503 E:4507 ||| DT
breast  ||| S:4507 E:4514 ||| NN
and  ||| S:4514 E:4518 ||| CC
ovarian  ||| S:4518 E:4534 ||| JJ
cancer  ||| S:4534 E:4541 ||| NN
susceptibility  ||| S:4541 E:4556 ||| NN
gene ||| S:4556 E:4560 ||| NN
,  ||| S:4560 E:4562 ||| ,
BRCA1 ||| S:4562 E:4567 ||| NNP
,  ||| S:4567 E:4569 ||| ,
showed  ||| S:4569 E:4576 ||| VBD
that  ||| S:4576 E:4589 ||| DT
disease-associated  ||| S:4589 E:4608 ||| JJ
mutations  ||| S:4608 E:4618 ||| NNS
tend  ||| S:4618 E:4623 ||| VBP
to  ||| S:4623 E:4626 ||| TO
occur  ||| S:4626 E:4632 ||| VB
in  ||| S:4632 E:4635 ||| IN
highly  ||| S:4635 E:4650 ||| RB
conserved  ||| S:4650 E:4660 ||| JJ
regions  ||| S:4660 E:4668 ||| NNS
[  ||| S:4668 E:4670 ||| -LRB-
18  ||| S:4670 E:4673 ||| CD
]  ||| S:4673 E:4675 ||| -RRB-
.  ||| S:4675 E:4677 ||| .
An  ||| S:4677 E:4680 ||| DT
analysis  ||| S:4680 E:4689 ||| NN
of  ||| S:4689 E:4692 ||| IN
homologous  ||| S:4692 E:4711 ||| JJ
sequences  ||| S:4711 E:4721 ||| NN
in  ||| S:4721 E:4724 ||| IN
the  ||| S:4724 E:4728 ||| DT
androgen  ||| S:4728 E:4737 ||| JJ
receptor  ||| S:4737 E:4746 ||| NN
has  ||| S:4746 E:4750 ||| VBZ
shown  ||| S:4750 E:4756 ||| VBN
similar  ||| S:4756 E:4772 ||| JJ
results  ||| S:4772 E:4780 ||| NNS
[  ||| S:4780 E:4782 ||| -LRB-
10  ||| S:4782 E:4785 ||| CD
]  ||| S:4785 E:4787 ||| -RRB-
.  ||| S:4787 E:4789 ||| .
Keratin  ||| S:4789 E:4797 ||| NNP
12 ||| S:4797 E:4799 ||| CD
,  ||| S:4799 E:4801 ||| ,
KRT12 ||| S:4801 E:4806 ||| NNP
,  ||| S:4806 E:4808 ||| ,
is  ||| S:4808 E:4811 ||| VBZ
associated  ||| S:4811 E:4822 ||| VBN
with  ||| S:4822 E:4835 ||| IN
Meesmann  ||| S:4835 E:4844 ||| NNP
Corneal  ||| S:4844 E:4852 ||| NNP
Epithelial  ||| S:4852 E:4863 ||| NNP
Dystrophy  ||| S:4863 E:4873 ||| NNP
( ||| S:4873 E:4874 ||| -LRB-
MCD ||| S:4874 E:4877 ||| NNP
) ||| S:4877 E:4878 ||| -RRB-
.  ||| S:4878 E:4880 ||| .
Reported  ||| S:4880 E:4897 ||| VBN
mutations  ||| S:4897 E:4907 ||| NNS
often  ||| S:4907 E:4913 ||| RB
occur  ||| S:4913 E:4919 ||| VB
in  ||| S:4919 E:4922 ||| IN
the  ||| S:4922 E:4926 ||| DT
highly  ||| S:4926 E:4933 ||| RB
conserved  ||| S:4933 E:4951 ||| JJ
alpha-helix-initiation  ||| S:4951 E:4974 ||| JJ
motif  ||| S:4974 E:4980 ||| NN
of  ||| S:4980 E:4983 ||| IN
rod  ||| S:4983 E:4987 ||| NN
domain  ||| S:4987 E:4994 ||| NN
1A  ||| S:4994 E:4997 ||| NN
or  ||| S:4997 E:5000 ||| CC
in  ||| S:5000 E:5003 ||| IN
the  ||| S:5003 E:5015 ||| DT
alpha-helix-termination  ||| S:5015 E:5039 ||| JJ
motif  ||| S:5039 E:5045 ||| NN
of  ||| S:5045 E:5048 ||| IN
rod  ||| S:5048 E:5052 ||| FW
domain  ||| S:5052 E:5059 ||| FW
2B  ||| S:5059 E:5062 ||| FW
[  ||| S:5062 E:5064 ||| -LRB-
19  ||| S:5064 E:5067 ||| CD
]  ||| S:5067 E:5069 ||| -RRB-
.  ||| S:5069 E:5079 ||| .
Structure  ||| S:5079 E:5089 ||| NN
based  ||| S:5089 E:5095 ||| VBN
analysis  ||| S:5095 E:5104 ||| NN
methods  ||| S:5104 E:5112 ||| NNS
have  ||| S:5112 E:5117 ||| VBP
also  ||| S:5117 E:5122 ||| RB
been  ||| S:5122 E:5127 ||| VBN
used  ||| S:5127 E:5132 ||| VBN
to  ||| S:5132 E:5143 ||| TO
analyze  ||| S:5143 E:5151 ||| VB
Osteogenesis  ||| S:5151 E:5164 ||| NNP
imperfecta  ||| S:5164 E:5175 ||| VBD
associated  ||| S:5175 E:5186 ||| VBN
COL1A1  ||| S:5186 E:5193 ||| CD
mutations  ||| S:5193 E:5211 ||| NNS
and  ||| S:5211 E:5215 ||| CC
disease-associated  ||| S:5215 E:5234 ||| JJ
P53  ||| S:5234 E:5238 ||| CD
mutations  ||| S:5238 E:5248 ||| NNS
( ||| S:5248 E:5249 ||| -LRB-
Mooney  ||| S:5249 E:5256 ||| NNP
and  ||| S:5256 E:5260 ||| CC
Klein ||| S:5260 E:5265 ||| NNP
,  ||| S:5265 E:5275 ||| ,
unpublished ||| S:5275 E:5286 ||| JJ
) ||| S:5286 E:5287 ||| -RRB-
,  ||| S:5287 E:5289 ||| ,
[  ||| S:5289 E:5291 ||| -LRB-
20  ||| S:5291 E:5294 ||| CD
]  ||| S:5294 E:5296 ||| -RRB-
.  ||| S:5296 E:5298 ||| .
Miller  ||| S:5298 E:5305 ||| NNP
and  ||| S:5305 E:5309 ||| CC
Kumar  ||| S:5309 E:5315 ||| NNP
have  ||| S:5315 E:5320 ||| VBP
reported  ||| S:5320 E:5329 ||| VBN
that  ||| S:5329 E:5342 ||| IN
disease-associated  ||| S:5342 E:5361 ||| JJ
mutations  ||| S:5361 E:5371 ||| NNS
are  ||| S:5371 E:5375 ||| VBP
conserved  ||| S:5375 E:5385 ||| VBN
in  ||| S:5385 E:5388 ||| IN
seven  ||| S:5388 E:5394 ||| CD
model  ||| S:5394 E:5408 ||| NN
genes  ||| S:5408 E:5414 ||| NNS
[  ||| S:5414 E:5416 ||| -LRB-
21  ||| S:5416 E:5419 ||| CD
]  ||| S:5419 E:5421 ||| -RRB-
.  ||| S:5421 E:5431 ||| .
To  ||| S:5431 E:5434 ||| TO
determine  ||| S:5434 E:5444 ||| VB
the  ||| S:5444 E:5448 ||| DT
degree  ||| S:5448 E:5455 ||| NN
to  ||| S:5455 E:5458 ||| TO
which  ||| S:5458 E:5464 ||| WDT
mutation  ||| S:5464 E:5473 ||| VBP
positions  ||| S:5473 E:5491 ||| NNS
differ  ||| S:5491 E:5498 ||| VBP
evolutionarily  ||| S:5498 E:5513 ||| VBN
from  ||| S:5513 E:5518 ||| IN
other  ||| S:5518 E:5524 ||| JJ
positions ||| S:5524 E:5533 ||| NNS
,  ||| S:5533 E:5535 ||| ,
we  ||| S:5535 E:5538 ||| PRP
have  ||| S:5538 E:5543 ||| VBP
built  ||| S:5543 E:5557 ||| VBN
alignments  ||| S:5557 E:5568 ||| VBN
of  ||| S:5568 E:5571 ||| IN
homologous  ||| S:5571 E:5582 ||| JJ
genes  ||| S:5582 E:5588 ||| NNS
for  ||| S:5588 E:5592 ||| IN
231  ||| S:5592 E:5596 ||| CD
disease-associated  ||| S:5596 E:5623 ||| JJ
genes ||| S:5623 E:5628 ||| NNS
.  ||| S:5628 E:5630 ||| .
These  ||| S:5630 E:5636 ||| DT
multiple  ||| S:5636 E:5645 ||| JJ
alignments  ||| S:5645 E:5656 ||| NNS
have  ||| S:5656 E:5661 ||| VBP
then  ||| S:5661 E:5666 ||| RB
been  ||| S:5666 E:5671 ||| VBN
used  ||| S:5671 E:5676 ||| VBN
to  ||| S:5676 E:5687 ||| TO
assess  ||| S:5687 E:5694 ||| VB
the  ||| S:5694 E:5698 ||| DT
difference  ||| S:5698 E:5709 ||| NN
in  ||| S:5709 E:5712 ||| IN
evolutionary  ||| S:5712 E:5725 ||| JJ
conservation  ||| S:5725 E:5738 ||| NN
for  ||| S:5738 E:5750 ||| IN
positions  ||| S:5750 E:5760 ||| NNS
that  ||| S:5760 E:5765 ||| WDT
are  ||| S:5765 E:5769 ||| VBP
both  ||| S:5769 E:5774 ||| DT
disease-associated  ||| S:5774 E:5793 ||| JJ
and  ||| S:5793 E:5797 ||| CC
not  ||| S:5797 E:5809 ||| RB
associated ||| S:5809 E:5819 ||| VBN
.  ||| S:5819 E:5821 ||| .
The  ||| S:5821 E:5825 ||| DT
results  ||| S:5825 E:5833 ||| NNS
show  ||| S:5833 E:5838 ||| VBP
that ||| S:5838 E:5842 ||| RB
,  ||| S:5842 E:5844 ||| ,
in  ||| S:5844 E:5847 ||| IN
general ||| S:5847 E:5854 ||| JJ
,  ||| S:5854 E:5856 ||| ,
positions  ||| S:5856 E:5874 ||| NNS
with  ||| S:5874 E:5879 ||| IN
disease-associated  ||| S:5879 E:5898 ||| JJ
mutations  ||| S:5898 E:5908 ||| NNS
are  ||| S:5908 E:5912 ||| VBP
conserved  ||| S:5912 E:5922 ||| VBG
more  ||| S:5922 E:5927 ||| JJR
than  ||| S:5927 E:5940 ||| IN
the  ||| S:5940 E:5944 ||| DT
average  ||| S:5944 E:5952 ||| JJ
position  ||| S:5952 E:5961 ||| NN
in  ||| S:5961 E:5964 ||| IN
the  ||| S:5964 E:5968 ||| DT
alignment ||| S:5968 E:5977 ||| NN
.  ||| S:5977 E:5979 ||| .
This  ||| S:5979 E:5984 ||| DT
suggests  ||| S:5984 E:5993 ||| VBZ
the  ||| S:5993 E:6005 ||| DT
most  ||| S:6005 E:6010 ||| RBS
conserved  ||| S:6010 E:6020 ||| JJ
mutations  ||| S:6020 E:6030 ||| NNS
are  ||| S:6030 E:6034 ||| VBP
likely  ||| S:6034 E:6041 ||| JJ
to  ||| S:6041 E:6044 ||| TO
be  ||| S:6044 E:6047 ||| VB
the  ||| S:6047 E:6051 ||| DT
causative  ||| S:6051 E:6069 ||| JJ
agents  ||| S:6069 E:6076 ||| NNS
of  ||| S:6076 E:6079 ||| IN
disease ||| S:6079 E:6086 ||| NN
,  ||| S:6086 E:6088 ||| ,
and  ||| S:6088 E:6092 ||| CC
our  ||| S:6092 E:6096 ||| PRP$
data  ||| S:6096 E:6101 ||| NNS
set  ||| S:6101 E:6105 ||| VBP
identifies  ||| S:6105 E:6116 ||| VBG
these  ||| S:6116 E:6130 ||| DT
mutations ||| S:6130 E:6139 ||| NN
.  ||| S:6139 E:6163 ||| .
Results  ||| S:6163 E:6171 ||| NNS
and  ||| S:6171 E:6175 ||| CC
Discussion  ||| S:6175 E:6194 ||| VBG
Our  ||| S:6194 E:6198 ||| PRP$
method  ||| S:6198 E:6205 ||| NN
compares  ||| S:6205 E:6214 ||| VBZ
the  ||| S:6214 E:6218 ||| DT
negative  ||| S:6218 E:6227 ||| JJ
entropy  ||| S:6227 E:6235 ||| NN
of  ||| S:6235 E:6246 ||| IN
disease-associated  ||| S:6246 E:6265 ||| JJ
columns  ||| S:6265 E:6273 ||| NNS
within  ||| S:6273 E:6280 ||| IN
an  ||| S:6280 E:6283 ||| DT
alignment  ||| S:6283 E:6293 ||| NN
to  ||| S:6293 E:6296 ||| TO
other  ||| S:6296 E:6310 ||| JJ
columns  ||| S:6310 E:6318 ||| NNS
in  ||| S:6318 E:6321 ||| IN
that  ||| S:6321 E:6326 ||| DT
alignment ||| S:6326 E:6335 ||| NN
.  ||| S:6335 E:6337 ||| .
The  ||| S:6337 E:6341 ||| DT
goal  ||| S:6341 E:6346 ||| NN
of  ||| S:6346 E:6349 ||| IN
this  ||| S:6349 E:6354 ||| DT
work  ||| S:6354 E:6359 ||| NN
is  ||| S:6359 E:6362 ||| VBZ
to  ||| S:6362 E:6373 ||| TO
build  ||| S:6373 E:6379 ||| VB
these  ||| S:6379 E:6385 ||| DT
alignments ||| S:6385 E:6395 ||| NN
,  ||| S:6395 E:6397 ||| ,
map  ||| S:6397 E:6401 ||| VBG
the  ||| S:6401 E:6405 ||| DT
mutations  ||| S:6405 E:6415 ||| NN
to  ||| S:6415 E:6418 ||| TO
them ||| S:6418 E:6422 ||| PRP
,  ||| S:6422 E:6424 ||| ,
and  ||| S:6424 E:6428 ||| CC
show  ||| S:6428 E:6441 ||| NN
that  ||| S:6441 E:6446 ||| IN
disease-associated  ||| S:6446 E:6465 ||| JJ
positions  ||| S:6465 E:6475 ||| NNS
are ||| S:6475 E:6478 ||| VBP
,  ||| S:6478 E:6480 ||| ,
in  ||| S:6480 E:6483 ||| IN
general ||| S:6483 E:6490 ||| JJ
,  ||| S:6490 E:6500 ||| ,
conserved ||| S:6500 E:6509 ||| NN
.  ||| S:6509 E:6511 ||| .
The  ||| S:6511 E:6515 ||| DT
analysis  ||| S:6515 E:6524 ||| NN
was  ||| S:6524 E:6528 ||| VBD
performed  ||| S:6528 E:6538 ||| VBN
on  ||| S:6538 E:6541 ||| IN
the  ||| S:6541 E:6545 ||| DT
built  ||| S:6545 E:6559 ||| VBN
alignments  ||| S:6559 E:6570 ||| NNS
and  ||| S:6570 E:6574 ||| CC
the  ||| S:6574 E:6578 ||| DT
results  ||| S:6578 E:6586 ||| NNS
are  ||| S:6586 E:6590 ||| VBP
shown  ||| S:6590 E:6596 ||| VBN
in  ||| S:6596 E:6599 ||| IN
Table  ||| S:6599 E:6605 ||| NNP
1 ||| S:6605 E:6606 ||| CD
.  ||| S:6606 E:6616 ||| .
To  ||| S:6616 E:6619 ||| TO
collect  ||| S:6619 E:6627 ||| VB
the  ||| S:6627 E:6631 ||| DT
mutation  ||| S:6631 E:6640 ||| JJ
data ||| S:6640 E:6644 ||| NNS
,  ||| S:6644 E:6646 ||| ,
231  ||| S:6646 E:6650 ||| CD
genes  ||| S:6650 E:6656 ||| NNS
were  ||| S:6656 E:6661 ||| VBD
used  ||| S:6661 E:6666 ||| VBN
for  ||| S:6666 E:6678 ||| IN
the  ||| S:6678 E:6682 ||| DT
analysis ||| S:6682 E:6690 ||| NN
.  ||| S:6690 E:6692 ||| .
They  ||| S:6692 E:6697 ||| PRP
were  ||| S:6697 E:6702 ||| VBD
chosen  ||| S:6702 E:6709 ||| VBN
because  ||| S:6709 E:6717 ||| IN
they  ||| S:6717 E:6722 ||| PRP
had  ||| S:6722 E:6726 ||| VBD
a  ||| S:6726 E:6728 ||| DT
reported  ||| S:6728 E:6745 ||| VBN
cDNA  ||| S:6745 E:6750 ||| JJ
sequence ||| S:6750 E:6758 ||| NN
,  ||| S:6758 E:6760 ||| ,
disease-associated  ||| S:6760 E:6779 ||| JJ
mutations  ||| S:6779 E:6789 ||| NNS
and  ||| S:6789 E:6793 ||| CC
homologs  ||| S:6793 E:6802 ||| NN
in  ||| S:6802 E:6813 ||| IN
SWISSPROT ||| S:6813 E:6822 ||| NNP
.  ||| S:6822 E:6824 ||| .
These  ||| S:6824 E:6830 ||| DT
genes  ||| S:6830 E:6836 ||| NNS
are  ||| S:6836 E:6840 ||| VBP
listed  ||| S:6840 E:6847 ||| VBN
in  ||| S:6847 E:6850 ||| IN
Table  ||| S:6850 E:6856 ||| NNP
1 ||| S:6856 E:6857 ||| CD
.  ||| S:6857 E:6859 ||| .
Each  ||| S:6859 E:6872 ||| DT
alignment  ||| S:6872 E:6882 ||| NN
consists  ||| S:6882 E:6891 ||| VBZ
of  ||| S:6891 E:6894 ||| IN
all  ||| S:6894 E:6898 ||| PDT
the  ||| S:6898 E:6902 ||| DT
homologs  ||| S:6902 E:6911 ||| NN
in  ||| S:6911 E:6914 ||| IN
SWISSPROT  ||| S:6914 E:6924 ||| NNP
as  ||| S:6924 E:6935 ||| RB
determined  ||| S:6935 E:6946 ||| VBN
by  ||| S:6946 E:6949 ||| IN
a  ||| S:6949 E:6951 ||| DT
BLAST  ||| S:6951 E:6957 ||| NN
search  ||| S:6957 E:6964 ||| NN
with  ||| S:6964 E:6969 ||| IN
an  ||| S:6969 E:6972 ||| DT
e-value  ||| S:6972 E:6980 ||| JJ
threshold  ||| S:6980 E:6990 ||| NN
of  ||| S:6990 E:7001 ||| IN
10e-15 ||| S:7001 E:7007 ||| CD
.  ||| S:7007 E:7009 ||| .
For  ||| S:7009 E:7013 ||| IN
each  ||| S:7013 E:7018 ||| DT
alignment  ||| S:7018 E:7028 ||| NN
the  ||| S:7028 E:7032 ||| DT
negative  ||| S:7032 E:7041 ||| JJ
entropy  ||| S:7041 E:7049 ||| NN
for  ||| S:7049 E:7053 ||| IN
each  ||| S:7053 E:7066 ||| DT
column  ||| S:7066 E:7073 ||| NN
was  ||| S:7073 E:7077 ||| VBD
calculated ||| S:7077 E:7087 ||| VBN
.  ||| S:7087 E:7097 ||| .
The  ||| S:7097 E:7101 ||| DT
conservation  ||| S:7101 E:7114 ||| NN
ratio  ||| S:7114 E:7120 ||| NN
parameter  ||| S:7120 E:7130 ||| NN
is  ||| S:7130 E:7133 ||| VBZ
defined  ||| S:7133 E:7141 ||| VBN
as  ||| S:7141 E:7144 ||| IN
the  ||| S:7144 E:7156 ||| DT
average  ||| S:7156 E:7164 ||| JJ
negative  ||| S:7164 E:7173 ||| JJ
entropy  ||| S:7173 E:7181 ||| NN
of  ||| S:7181 E:7184 ||| IN
analyzable  ||| S:7184 E:7195 ||| JJ
positions  ||| S:7195 E:7205 ||| NNS
with  ||| S:7205 E:7218 ||| IN
reported  ||| S:7218 E:7227 ||| JJ
mutations  ||| S:7227 E:7237 ||| NNS
divided  ||| S:7237 E:7245 ||| VBN
by  ||| S:7245 E:7248 ||| IN
the  ||| S:7248 E:7252 ||| DT
average  ||| S:7252 E:7260 ||| JJ
negative  ||| S:7260 E:7269 ||| JJ
entropy  ||| S:7269 E:7285 ||| NN
of  ||| S:7285 E:7288 ||| IN
every  ||| S:7288 E:7294 ||| DT
analyzable  ||| S:7294 E:7305 ||| JJ
position  ||| S:7305 E:7314 ||| NN
in  ||| S:7314 E:7317 ||| IN
the  ||| S:7317 E:7321 ||| DT
gene  ||| S:7321 E:7326 ||| NN
sequence ||| S:7326 E:7334 ||| NN
.  ||| S:7334 E:7336 ||| .
Analysis  ||| S:7336 E:7353 ||| NNP
was  ||| S:7353 E:7357 ||| VBD
performed  ||| S:7357 E:7367 ||| VBN
on  ||| S:7367 E:7370 ||| IN
231  ||| S:7370 E:7374 ||| CD
genes  ||| S:7374 E:7380 ||| NNS
and  ||| S:7380 E:7384 ||| CC
6185  ||| S:7384 E:7389 ||| CD
mutations  ||| S:7389 E:7399 ||| NNS
and  ||| S:7399 E:7403 ||| CC
of  ||| S:7403 E:7406 ||| IN
those  ||| S:7406 E:7420 ||| DT
we  ||| S:7420 E:7423 ||| PRP
found  ||| S:7423 E:7429 ||| VBD
that  ||| S:7429 E:7434 ||| IN
84.0 ||| S:7434 E:7438 ||| CD
%  ||| S:7438 E:7440 ||| NN
had  ||| S:7440 E:7444 ||| VBD
conservation  ||| S:7444 E:7457 ||| JJ
ratios  ||| S:7457 E:7464 ||| NNS
less  ||| S:7464 E:7469 ||| RBR
than  ||| S:7469 E:7474 ||| IN
one ||| S:7474 E:7477 ||| CD
.  ||| S:7477 E:7487 ||| .
From  ||| S:7487 E:7492 ||| IN
those ||| S:7492 E:7497 ||| DT
,  ||| S:7497 E:7499 ||| ,
139  ||| S:7499 E:7503 ||| CD
genes  ||| S:7503 E:7509 ||| NNS
had  ||| S:7509 E:7513 ||| VBD
more  ||| S:7513 E:7518 ||| JJR
than  ||| S:7518 E:7523 ||| IN
ten  ||| S:7523 E:7527 ||| JJ
analyzable  ||| S:7527 E:7546 ||| JJ
mutations  ||| S:7546 E:7556 ||| NNS
and ||| S:7556 E:7559 ||| CC
,  ||| S:7559 E:7561 ||| ,
of  ||| S:7561 E:7564 ||| IN
those ||| S:7564 E:7569 ||| DT
,  ||| S:7569 E:7571 ||| ,
88.0 ||| S:7571 E:7575 ||| CD
%  ||| S:7575 E:7577 ||| NN
had  ||| S:7577 E:7581 ||| VBD
conservation  ||| S:7581 E:7594 ||| JJ
ratios  ||| S:7594 E:7601 ||| NNS
less  ||| S:7601 E:7614 ||| RBR
than  ||| S:7614 E:7619 ||| IN
one ||| S:7619 E:7622 ||| CD
.  ||| S:7622 E:7632 ||| .
Use  ||| S:7632 E:7636 ||| NN
of  ||| S:7636 E:7639 ||| IN
evolutionary  ||| S:7639 E:7652 ||| JJ
information  ||| S:7652 E:7664 ||| NN
is  ||| S:7664 E:7667 ||| VBZ
a  ||| S:7667 E:7669 ||| DT
promising  ||| S:7669 E:7679 ||| JJ
approach  ||| S:7679 E:7696 ||| NN
to  ||| S:7696 E:7699 ||| TO
automated  ||| S:7699 E:7709 ||| JJ
characterization  ||| S:7709 E:7726 ||| NN
of  ||| S:7726 E:7729 ||| IN
mutations ||| S:7729 E:7738 ||| NNS
.  ||| S:7738 E:7740 ||| .
These  ||| S:7740 E:7746 ||| DT
results  ||| S:7746 E:7762 ||| NNS
show  ||| S:7762 E:7767 ||| VBP
that  ||| S:7767 E:7772 ||| IN
although  ||| S:7772 E:7781 ||| IN
conservation  ||| S:7781 E:7794 ||| NN
alone  ||| S:7794 E:7800 ||| RB
is  ||| S:7800 E:7803 ||| VBZ
not  ||| S:7803 E:7807 ||| RB
a  ||| S:7807 E:7809 ||| DT
perfect  ||| S:7809 E:7825 ||| JJ
predictive  ||| S:7825 E:7836 ||| JJ
measure ||| S:7836 E:7843 ||| NN
,  ||| S:7843 E:7845 ||| ,
there  ||| S:7845 E:7851 ||| EX
is  ||| S:7851 E:7854 ||| VBZ
useful  ||| S:7854 E:7861 ||| JJ
information  ||| S:7861 E:7873 ||| NN
contained  ||| S:7873 E:7891 ||| VBN
in  ||| S:7891 E:7894 ||| IN
sequence  ||| S:7894 E:7903 ||| JJ
alignments  ||| S:7903 E:7914 ||| NNS
containing  ||| S:7914 E:7925 ||| VBG
homologous  ||| S:7925 E:7936 ||| JJ
genes ||| S:7936 E:7941 ||| NNS
.  ||| S:7941 E:7951 ||| .
Approaches  ||| S:7951 E:7962 ||| NNS
using  ||| S:7962 E:7968 ||| VBG
conservation  ||| S:7968 E:7981 ||| NN
in  ||| S:7981 E:7984 ||| IN
a  ||| S:7984 E:7986 ||| DT
multiple  ||| S:7986 E:7995 ||| JJ
alignment  ||| S:7995 E:8013 ||| NN
should  ||| S:8013 E:8020 ||| MD
work  ||| S:8020 E:8025 ||| VB
better  ||| S:8025 E:8032 ||| JJR
when  ||| S:8032 E:8037 ||| WRB
associated  ||| S:8037 E:8048 ||| VBN
with  ||| S:8048 E:8053 ||| IN
other  ||| S:8053 E:8059 ||| JJ
methods  ||| S:8059 E:8067 ||| NNS
such  ||| S:8067 E:8080 ||| JJ
as  ||| S:8080 E:8083 ||| IN
structural  ||| S:8083 E:8094 ||| JJ
analysis ||| S:8094 E:8102 ||| NN
,  ||| S:8102 E:8104 ||| ,
population  ||| S:8104 E:8115 ||| NN
analysis  ||| S:8115 E:8124 ||| NN
and  ||| S:8124 E:8136 ||| CC
experimental  ||| S:8136 E:8149 ||| JJ
data ||| S:8149 E:8153 ||| NNS
.  ||| S:8153 E:8155 ||| .
Knowledge  ||| S:8155 E:8165 ||| NN
of  ||| S:8165 E:8168 ||| IN
how  ||| S:8168 E:8172 ||| WRB
the  ||| S:8172 E:8176 ||| DT
sequence  ||| S:8176 E:8185 ||| JJ
pool  ||| S:8185 E:8198 ||| NN
clusters  ||| S:8198 E:8207 ||| NNS
into  ||| S:8207 E:8212 ||| IN
families  ||| S:8212 E:8221 ||| NNS
may  ||| S:8221 E:8225 ||| MD
increase  ||| S:8225 E:8234 ||| VB
the  ||| S:8234 E:8238 ||| DT
sensitivity  ||| S:8238 E:8250 ||| NN
of  ||| S:8250 E:8253 ||| IN
the  ||| S:8253 E:8265 ||| DT
method ||| S:8265 E:8271 ||| NN
.  ||| S:8271 E:8281 ||| .
Our  ||| S:8281 E:8285 ||| PRP$
measured  ||| S:8285 E:8294 ||| JJ
parameter ||| S:8294 E:8303 ||| NN
,  ||| S:8303 E:8305 ||| ,
the  ||| S:8305 E:8309 ||| DT
conservation  ||| S:8309 E:8322 ||| NN
ratio ||| S:8322 E:8327 ||| NN
,  ||| S:8327 E:8329 ||| ,
is  ||| S:8329 E:8332 ||| VBZ
a  ||| S:8332 E:8342 ||| DT
quantity  ||| S:8342 E:8351 ||| NN
that  ||| S:8351 E:8356 ||| WDT
measures  ||| S:8356 E:8365 ||| VBZ
the  ||| S:8365 E:8369 ||| DT
usefulness  ||| S:8369 E:8380 ||| NN
of  ||| S:8380 E:8383 ||| IN
a  ||| S:8383 E:8385 ||| DT
multiple  ||| S:8385 E:8402 ||| JJ
alignment  ||| S:8402 E:8412 ||| NN
for  ||| S:8412 E:8416 ||| IN
characterizing  ||| S:8416 E:8431 ||| JJ
mutations  ||| S:8431 E:8441 ||| NNS
in  ||| S:8441 E:8444 ||| IN
a  ||| S:8444 E:8446 ||| DT
gene  ||| S:8446 E:8451 ||| NN
sequence ||| S:8451 E:8459 ||| NN
.  ||| S:8459 E:8469 ||| .
Knowledge  ||| S:8469 E:8479 ||| NN
of  ||| S:8479 E:8482 ||| IN
more  ||| S:8482 E:8487 ||| JJR
mutations  ||| S:8487 E:8497 ||| NNS
in  ||| S:8497 E:8500 ||| IN
a  ||| S:8500 E:8502 ||| DT
gene  ||| S:8502 E:8507 ||| NN
does  ||| S:8507 E:8512 ||| VBZ
not  ||| S:8512 E:8516 ||| RB
necessarily  ||| S:8516 E:8536 ||| RB
lower  ||| S:8536 E:8542 ||| VB
the  ||| S:8542 E:8546 ||| DT
conservation  ||| S:8546 E:8559 ||| NN
ratio ||| S:8559 E:8564 ||| NN
.  ||| S:8564 E:8566 ||| .
We  ||| S:8566 E:8569 ||| PRP
expect  ||| S:8569 E:8576 ||| VBP
that  ||| S:8576 E:8581 ||| DT
knowledge  ||| S:8581 E:8591 ||| NN
of  ||| S:8591 E:8602 ||| IN
more  ||| S:8602 E:8607 ||| JJR
mutations  ||| S:8607 E:8617 ||| NNS
in  ||| S:8617 E:8620 ||| IN
a  ||| S:8620 E:8622 ||| DT
gene  ||| S:8622 E:8627 ||| NN
will  ||| S:8627 E:8632 ||| MD
increase  ||| S:8632 E:8641 ||| VB
the  ||| S:8641 E:8645 ||| DT
statistical  ||| S:8645 E:8665 ||| JJ
significance  ||| S:8665 E:8678 ||| NN
of  ||| S:8678 E:8681 ||| IN
the  ||| S:8681 E:8685 ||| DT
conservation  ||| S:8685 E:8698 ||| NN
ratio ||| S:8698 E:8703 ||| NN
.  ||| S:8703 E:8705 ||| .
This  ||| S:8705 E:8710 ||| DT
is  ||| S:8710 E:8713 ||| VBZ
the  ||| S:8713 E:8717 ||| DT
likely  ||| S:8717 E:8732 ||| JJ
underlying  ||| S:8732 E:8743 ||| JJ
cause  ||| S:8743 E:8749 ||| NN
of  ||| S:8749 E:8752 ||| IN
the  ||| S:8752 E:8756 ||| DT
result  ||| S:8756 E:8763 ||| NN
showing  ||| S:8763 E:8771 ||| VBG
that  ||| S:8771 E:8776 ||| IN
genes  ||| S:8776 E:8782 ||| NNS
with  ||| S:8782 E:8787 ||| IN
10  ||| S:8787 E:8798 ||| CD
or  ||| S:8798 E:8801 ||| CC
mutations  ||| S:8801 E:8811 ||| JJ
increases  ||| S:8811 E:8821 ||| NNS
are  ||| S:8821 E:8825 ||| VBP
more  ||| S:8825 E:8830 ||| RBR
likely  ||| S:8830 E:8837 ||| JJ
to  ||| S:8837 E:8840 ||| TO
have  ||| S:8840 E:8845 ||| VB
a  ||| S:8845 E:8855 ||| DT
conservation  ||| S:8855 E:8868 ||| NN
ratio  ||| S:8868 E:8874 ||| NN
less  ||| S:8874 E:8879 ||| RBR
than  ||| S:8879 E:8884 ||| IN
one ||| S:8884 E:8887 ||| CD
.  ||| S:8887 E:8897 ||| .
The  ||| S:8897 E:8901 ||| DT
alignments  ||| S:8901 E:8912 ||| NN
and  ||| S:8912 E:8916 ||| CC
BLAST  ||| S:8916 E:8922 ||| NN
searches  ||| S:8922 E:8931 ||| NNS
are  ||| S:8931 E:8935 ||| VBP
integrated  ||| S:8935 E:8946 ||| VBN
on  ||| S:8946 E:8949 ||| IN
the  ||| S:8949 E:8961 ||| DT
website ||| S:8961 E:8968 ||| NN
,  ||| S:8968 E:8970 ||| ,
http://cancer.stanford.edu/mut-paper/ ||| S:8970 E:9007 ||| NNP
.  ||| S:9007 E:9031 ||| .
Conclusions  ||| S:9031 E:9051 ||| NNS
In  ||| S:9051 E:9054 ||| IN
conclusion ||| S:9054 E:9064 ||| NN
,  ||| S:9064 E:9066 ||| ,
there  ||| S:9066 E:9072 ||| EX
are  ||| S:9072 E:9076 ||| VBP
estimated  ||| S:9076 E:9086 ||| VBN
to  ||| S:9086 E:9089 ||| TO
be  ||| S:9089 E:9092 ||| VB
30,000  ||| S:9092 E:9107 ||| CD
non-synonymous  ||| S:9107 E:9122 ||| JJ
differences  ||| S:9122 E:9134 ||| NNS
between  ||| S:9134 E:9142 ||| IN
an  ||| S:9142 E:9145 ||| DT
individual  ||| S:9145 E:9156 ||| JJ
and  ||| S:9156 E:9160 ||| CC
the  ||| S:9160 E:9172 ||| DT
draft  ||| S:9172 E:9178 ||| NN
genome  ||| S:9178 E:9185 ||| NNS
[  ||| S:9185 E:9187 ||| -LRB-
23  ||| S:9187 E:9190 ||| CD
5  ||| S:9190 E:9192 ||| CD
7  ||| S:9192 E:9194 ||| CD
8  ||| S:9194 E:9196 ||| CD
9  ||| S:9196 E:9198 ||| CD
]  ||| S:9198 E:9200 ||| -RRB-
.  ||| S:9200 E:9202 ||| .
Determination  ||| S:9202 E:9216 ||| NN
of  ||| S:9216 E:9219 ||| IN
which  ||| S:9219 E:9233 ||| WDT
positions  ||| S:9233 E:9243 ||| NNS
are  ||| S:9243 E:9247 ||| VBP
likely  ||| S:9247 E:9254 ||| JJ
to  ||| S:9254 E:9257 ||| TO
be  ||| S:9257 E:9260 ||| VB
disease  ||| S:9260 E:9268 ||| NN
associated  ||| S:9268 E:9279 ||| VBN
is  ||| S:9279 E:9282 ||| VBZ
a  ||| S:9282 E:9292 ||| DT
challenging  ||| S:9292 E:9304 ||| JJ
and  ||| S:9304 E:9308 ||| CC
important  ||| S:9308 E:9318 ||| JJ
problem ||| S:9318 E:9325 ||| NN
.  ||| S:9325 E:9327 ||| .
The  ||| S:9327 E:9331 ||| DT
finding  ||| S:9331 E:9339 ||| NN
that  ||| S:9339 E:9352 ||| IN
disease-associated  ||| S:9352 E:9371 ||| JJ
mutations  ||| S:9371 E:9381 ||| NNS
occur  ||| S:9381 E:9387 ||| VBP
in  ||| S:9387 E:9390 ||| IN
positions  ||| S:9390 E:9400 ||| NNS
of  ||| S:9400 E:9411 ||| IN
functional  ||| S:9411 E:9422 ||| JJ
importance  ||| S:9422 E:9433 ||| NN
supports  ||| S:9433 E:9442 ||| VBZ
recent  ||| S:9442 E:9449 ||| JJ
efforts  ||| S:9449 E:9457 ||| NNS
for  ||| S:9457 E:9461 ||| IN
the  ||| S:9461 E:9473 ||| DT
building  ||| S:9473 E:9482 ||| NN
of  ||| S:9482 E:9485 ||| IN
methods  ||| S:9485 E:9493 ||| NNS
to  ||| S:9493 E:9496 ||| TO
predict  ||| S:9496 E:9504 ||| VB
which  ||| S:9504 E:9510 ||| WDT
positions  ||| S:9510 E:9520 ||| NNS
are  ||| S:9520 E:9524 ||| VBP
likely  ||| S:9524 E:9539 ||| JJ
to  ||| S:9539 E:9542 ||| TO
be  ||| S:9542 E:9545 ||| VB
disease  ||| S:9545 E:9553 ||| NN
associated  ||| S:9553 E:9564 ||| VBN
[  ||| S:9564 E:9566 ||| -LRB-
14  ||| S:9566 E:9569 ||| CD
13  ||| S:9569 E:9572 ||| CD
16  ||| S:9572 E:9575 ||| CD
17  ||| S:9575 E:9578 ||| CD
]  ||| S:9578 E:9580 ||| -RRB-
.  ||| S:9580 E:9582 ||| .
These  ||| S:9582 E:9588 ||| DT
methods  ||| S:9588 E:9604 ||| NNS
are  ||| S:9604 E:9608 ||| VBP
likely  ||| S:9608 E:9615 ||| JJ
to  ||| S:9615 E:9618 ||| TO
incorporate  ||| S:9618 E:9630 ||| VB
protein  ||| S:9630 E:9638 ||| NN
structure ||| S:9638 E:9647 ||| NN
,  ||| S:9647 E:9649 ||| ,
the  ||| S:9649 E:9653 ||| DT
amino  ||| S:9653 E:9659 ||| JJ
acid  ||| S:9659 E:9672 ||| NN
identity  ||| S:9672 E:9681 ||| NN
of  ||| S:9681 E:9684 ||| IN
the  ||| S:9684 E:9688 ||| DT
mutation  ||| S:9688 E:9697 ||| NN
and  ||| S:9697 E:9701 ||| CC
phylogenetic  ||| S:9701 E:9714 ||| JJ
information ||| S:9714 E:9725 ||| NN
.  ||| S:9725 E:9727 ||| .
In  ||| S:9727 E:9738 ||| IN
an  ||| S:9738 E:9741 ||| DT
interesting  ||| S:9741 E:9753 ||| JJ
twist ||| S:9753 E:9758 ||| NN
,  ||| S:9758 E:9760 ||| ,
this  ||| S:9760 E:9765 ||| DT
observation  ||| S:9765 E:9777 ||| NN
also  ||| S:9777 E:9782 ||| RB
suggests  ||| S:9782 E:9791 ||| VBZ
that  ||| S:9791 E:9804 ||| IN
this  ||| S:9804 E:9809 ||| DT
data  ||| S:9809 E:9814 ||| NNS
may  ||| S:9814 E:9818 ||| MD
be  ||| S:9818 E:9821 ||| VB
useable  ||| S:9821 E:9829 ||| VBN
as  ||| S:9829 E:9832 ||| IN
a  ||| S:9832 E:9834 ||| DT
functional  ||| S:9834 E:9845 ||| JJ
genomics  ||| S:9845 E:9854 ||| JJ
tool  ||| S:9854 E:9859 ||| NN
for  ||| S:9859 E:9871 ||| IN
understanding  ||| S:9871 E:9885 ||| VBG
the  ||| S:9885 E:9889 ||| DT
function  ||| S:9889 E:9898 ||| NN
of  ||| S:9898 E:9901 ||| IN
the  ||| S:9901 E:9905 ||| DT
protein  ||| S:9905 E:9913 ||| NN
products  ||| S:9913 E:9922 ||| NNS
of  ||| S:9922 E:9925 ||| IN
genes  ||| S:9925 E:9939 ||| NNS
on  ||| S:9939 E:9942 ||| IN
a  ||| S:9942 E:9944 ||| DT
molecular  ||| S:9944 E:9954 ||| JJ
level ||| S:9954 E:9959 ||| NN
.  ||| S:9959 E:9961 ||| .
Such  ||| S:9961 E:9966 ||| PDT
a  ||| S:9966 E:9968 ||| DT
method  ||| S:9968 E:9975 ||| NN
would  ||| S:9975 E:9981 ||| MD
use  ||| S:9981 E:9985 ||| VB
the  ||| S:9985 E:9989 ||| DT
inherent  ||| S:9989 E:10006 ||| JJ
functional  ||| S:10006 E:10017 ||| JJ
information  ||| S:10017 E:10029 ||| NN
contained  ||| S:10029 E:10039 ||| VBN
in  ||| S:10039 E:10042 ||| IN
a  ||| S:10042 E:10044 ||| DT
phenotypically  ||| S:10044 E:10067 ||| JJ
annotated  ||| S:10067 E:10077 ||| JJ
polymorphism  ||| S:10077 E:10090 ||| NN
to  ||| S:10090 E:10093 ||| TO
infer  ||| S:10093 E:10099 ||| VB
functional  ||| S:10099 E:10110 ||| JJ
importance  ||| S:10110 E:10129 ||| NN
within  ||| S:10129 E:10136 ||| IN
a  ||| S:10136 E:10138 ||| DT
gene ||| S:10138 E:10142 ||| NN
.  ||| S:10142 E:10166 ||| .
Methods  ||| S:10166 E:10182 ||| NNS
Non-synonymous  ||| S:10182 E:10197 ||| JJ
mutations  ||| S:10197 E:10207 ||| NNS
were  ||| S:10207 E:10212 ||| VBD
acquired  ||| S:10212 E:10221 ||| VBN
from  ||| S:10221 E:10226 ||| IN
the  ||| S:10226 E:10230 ||| DT
Human  ||| S:10230 E:10244 ||| NNP
Genome  ||| S:10244 E:10251 ||| NNP
Mutation  ||| S:10251 E:10260 ||| NNP
Database  ||| S:10260 E:10277 ||| NNP
http://archive.uwcm.ac.uk/uwcm/mg/hgmd0.html.  ||| S:10277 E:10323 ||| CD
231  ||| S:10323 E:10327 ||| CD
genes  ||| S:10327 E:10341 ||| NNS
were  ||| S:10341 E:10346 ||| VBD
chosen  ||| S:10346 E:10353 ||| VBN
with  ||| S:10353 E:10358 ||| IN
known  ||| S:10358 E:10364 ||| VBN
disease-association  ||| S:10364 E:10384 ||| JJ
each  ||| S:10384 E:10389 ||| DT
having  ||| S:10389 E:10404 ||| VBG
SWISSPROT  ||| S:10404 E:10414 ||| NNP
homologs ||| S:10414 E:10422 ||| NN
,  ||| S:10422 E:10424 ||| ,
a  ||| S:10424 E:10426 ||| DT
cDNA  ||| S:10426 E:10431 ||| JJ
sequence  ||| S:10431 E:10440 ||| NN
and  ||| S:10440 E:10444 ||| CC
mutations  ||| S:10444 E:10454 ||| NNS
in  ||| S:10454 E:10457 ||| IN
the  ||| S:10457 E:10469 ||| DT
coding  ||| S:10469 E:10476 ||| JJ
region ||| S:10476 E:10482 ||| NN
.  ||| S:10482 E:10484 ||| .
For  ||| S:10484 E:10488 ||| IN
each  ||| S:10488 E:10493 ||| DT
of  ||| S:10493 E:10496 ||| IN
those  ||| S:10496 E:10502 ||| DT
genes ||| S:10502 E:10507 ||| NNS
,  ||| S:10507 E:10509 ||| ,
all  ||| S:10509 E:10513 ||| DT
known  ||| S:10513 E:10527 ||| VBN
non-synonymous  ||| S:10527 E:10542 ||| JJ
mutations  ||| S:10542 E:10552 ||| NNS
were  ||| S:10552 E:10557 ||| VBD
then  ||| S:10557 E:10562 ||| RB
downloaded  ||| S:10562 E:10573 ||| VBN
with  ||| S:10573 E:10578 ||| IN
the  ||| S:10578 E:10582 ||| DT
cDNA  ||| S:10582 E:10595 ||| JJ
sequence  ||| S:10595 E:10604 ||| NN
for  ||| S:10604 E:10608 ||| IN
that  ||| S:10608 E:10613 ||| DT
gene ||| S:10613 E:10617 ||| NN
.  ||| S:10617 E:10627 ||| .
Each  ||| S:10627 E:10632 ||| DT
cDNA  ||| S:10632 E:10637 ||| JJ
sequence  ||| S:10637 E:10646 ||| NN
was  ||| S:10646 E:10650 ||| VBD
then  ||| S:10650 E:10655 ||| RB
translated  ||| S:10655 E:10666 ||| VBN
and  ||| S:10666 E:10670 ||| CC
placed  ||| S:10670 E:10677 ||| VBN
in  ||| S:10677 E:10680 ||| IN
a  ||| S:10680 E:10690 ||| DT
FASTA  ||| S:10690 E:10696 ||| NNP
formatted  ||| S:10696 E:10706 ||| JJ
file ||| S:10706 E:10710 ||| NN
.  ||| S:10710 E:10712 ||| .
For  ||| S:10712 E:10716 ||| IN
each  ||| S:10716 E:10721 ||| DT
of  ||| S:10721 E:10724 ||| IN
the  ||| S:10724 E:10728 ||| DT
resultant  ||| S:10728 E:10738 ||| NN
files  ||| S:10738 E:10744 ||| VBZ
a  ||| S:10744 E:10754 ||| DT
BLAST  ||| S:10754 E:10760 ||| NN
[  ||| S:10760 E:10762 ||| -LRB-
24  ||| S:10762 E:10765 ||| CD
]  ||| S:10765 E:10767 ||| -RRB-
search  ||| S:10767 E:10774 ||| NN
was  ||| S:10774 E:10778 ||| VBD
performed  ||| S:10778 E:10788 ||| VBN
against  ||| S:10788 E:10796 ||| IN
the  ||| S:10796 E:10800 ||| DT
SwissProt  ||| S:10800 E:10818 ||| JJ
database ||| S:10818 E:10826 ||| NN
.  ||| S:10826 E:10828 ||| .
All  ||| S:10828 E:10832 ||| DT
sequences  ||| S:10832 E:10842 ||| NN
from  ||| S:10842 E:10847 ||| IN
the  ||| S:10847 E:10851 ||| DT
returned  ||| S:10851 E:10860 ||| JJ
hits  ||| S:10860 E:10865 ||| NNS
were  ||| S:10865 E:10870 ||| VBD
then  ||| S:10870 E:10883 ||| RB
stored  ||| S:10883 E:10890 ||| VBN
in  ||| S:10890 E:10893 ||| IN
FASTA  ||| S:10893 E:10899 ||| NNP
format  ||| S:10899 E:10906 ||| NN
files ||| S:10906 E:10911 ||| NNS
.  ||| S:10911 E:10913 ||| .
For  ||| S:10913 E:10917 ||| IN
each  ||| S:10917 E:10922 ||| DT
of  ||| S:10922 E:10925 ||| IN
the  ||| S:10925 E:10929 ||| DT
genes  ||| S:10929 E:10935 ||| NNS
that  ||| S:10935 E:10948 ||| WDT
returned  ||| S:10948 E:10957 ||| VBD
BLAST  ||| S:10957 E:10963 ||| NN
results  ||| S:10963 E:10971 ||| NNS
with  ||| S:10971 E:10976 ||| IN
e-value  ||| S:10976 E:10984 ||| JJ
scores  ||| S:10984 E:10991 ||| NNS
smaller  ||| S:10991 E:10999 ||| JJR
than  ||| S:10999 E:11012 ||| IN
1e-15 ||| S:11012 E:11017 ||| NNP
,  ||| S:11017 E:11019 ||| ,
ClustalW  ||| S:11019 E:11028 ||| NNP
[  ||| S:11028 E:11030 ||| -LRB-
25  ||| S:11030 E:11033 ||| CD
]  ||| S:11033 E:11035 ||| -RRB-
was  ||| S:11035 E:11039 ||| VBD
used  ||| S:11039 E:11044 ||| VBN
to  ||| S:11044 E:11047 ||| TO
build  ||| S:11047 E:11053 ||| VB
a  ||| S:11053 E:11055 ||| DT
sequence  ||| S:11055 E:11072 ||| JJ
alignment ||| S:11072 E:11081 ||| NN
.  ||| S:11081 E:11091 ||| .
For  ||| S:11091 E:11095 ||| IN
each  ||| S:11095 E:11100 ||| DT
amino  ||| S:11100 E:11106 ||| JJ
acid  ||| S:11106 E:11111 ||| NN
in  ||| S:11111 E:11114 ||| IN
the  ||| S:11114 E:11118 ||| DT
position  ||| S:11118 E:11127 ||| NN
of  ||| S:11127 E:11130 ||| IN
interest ||| S:11130 E:11138 ||| NN
,  ||| S:11138 E:11140 ||| ,
the  ||| S:11140 E:11152 ||| DT
negative  ||| S:11152 E:11161 ||| JJ
entropy  ||| S:11161 E:11169 ||| NN
was  ||| S:11169 E:11173 ||| VBD
determined  ||| S:11173 E:11184 ||| VBN
using  ||| S:11184 E:11190 ||| VBG
the  ||| S:11190 E:11194 ||| DT
following  ||| S:11194 E:11204 ||| JJ
formula  ||| S:11204 E:11220 ||| NN
[  ||| S:11220 E:11222 ||| -LRB-
26  ||| S:11222 E:11225 ||| CD
]  ||| S:11225 E:11227 ||| -RRB-
:  ||| S:11227 E:11246 ||| :
Where  ||| S:11246 E:11252 ||| WRB
the  ||| S:11252 E:11256 ||| DT
P  ||| S:11256 E:11267 ||| NN
i  ||| S:11267 E:11269 ||| NNS
are  ||| S:11269 E:11273 ||| VBP
the  ||| S:11273 E:11277 ||| DT
probabilities  ||| S:11277 E:11291 ||| NN
of  ||| S:11291 E:11294 ||| IN
finding  ||| S:11294 E:11302 ||| VBG
a  ||| S:11302 E:11312 ||| DT
particular  ||| S:11312 E:11323 ||| JJ
amino  ||| S:11323 E:11329 ||| JJ
acid  ||| S:11329 E:11334 ||| NN
at  ||| S:11334 E:11337 ||| IN
that  ||| S:11337 E:11342 ||| DT
position ||| S:11342 E:11350 ||| NN
.  ||| S:11350 E:11352 ||| .
For  ||| S:11352 E:11356 ||| IN
this  ||| S:11356 E:11361 ||| DT
analysis ||| S:11361 E:11369 ||| NN
,  ||| S:11369 E:11379 ||| ,
gapped  ||| S:11379 E:11386 ||| JJ
positions ||| S:11386 E:11395 ||| NNS
,  ||| S:11395 E:11397 ||| ,
"- ||| S:11397 E:11399 ||| NNP
" ||| S:11399 E:11400 ||| ''
,  ||| S:11400 E:11402 ||| ,
were  ||| S:11402 E:11407 ||| VBD
considered  ||| S:11407 E:11418 ||| VBN
independent  ||| S:11418 E:11430 ||| JJ
amino  ||| S:11430 E:11444 ||| JJ
acids ||| S:11444 E:11449 ||| NNS
.  ||| S:11449 E:11459 ||| .
For  ||| S:11459 E:11463 ||| IN
each  ||| S:11463 E:11468 ||| DT
known  ||| S:11468 E:11474 ||| JJ
mutation ||| S:11474 E:11482 ||| NN
,  ||| S:11482 E:11484 ||| ,
the  ||| S:11484 E:11488 ||| DT
negative  ||| S:11488 E:11497 ||| JJ
entropy  ||| S:11497 E:11505 ||| NN
of  ||| S:11505 E:11508 ||| IN
the  ||| S:11508 E:11520 ||| DT
column  ||| S:11520 E:11527 ||| NN
it  ||| S:11527 E:11530 ||| PRP
occupies  ||| S:11530 E:11539 ||| VBZ
was  ||| S:11539 E:11543 ||| VBD
tabulated ||| S:11543 E:11552 ||| VBN
.  ||| S:11552 E:11554 ||| .
The  ||| S:11554 E:11558 ||| DT
average  ||| S:11558 E:11566 ||| JJ
negative  ||| S:11566 E:11583 ||| JJ
entropy  ||| S:11583 E:11591 ||| NN
for  ||| S:11591 E:11595 ||| IN
each  ||| S:11595 E:11600 ||| DT
mutation  ||| S:11600 E:11609 ||| NN
within  ||| S:11609 E:11616 ||| IN
a  ||| S:11616 E:11618 ||| DT
gene  ||| S:11618 E:11623 ||| NN
was  ||| S:11623 E:11627 ||| VBD
compared  ||| S:11627 E:11636 ||| VBN
to  ||| S:11636 E:11639 ||| TO
the  ||| S:11639 E:11651 ||| DT
average  ||| S:11651 E:11659 ||| JJ
entropy  ||| S:11659 E:11667 ||| NN
of  ||| S:11667 E:11670 ||| IN
all  ||| S:11670 E:11674 ||| DT
columns  ||| S:11674 E:11682 ||| NNS
satisfying  ||| S:11682 E:11693 ||| VBG
the  ||| S:11693 E:11697 ||| DT
criteria  ||| S:11697 E:11706 ||| NNS
for  ||| S:11706 E:11718 ||| IN
analysis ||| S:11718 E:11726 ||| NN
.  ||| S:11726 E:11728 ||| .
Mutations  ||| S:11728 E:11738 ||| JJ
outside  ||| S:11738 E:11746 ||| NN
of  ||| S:11746 E:11749 ||| IN
the  ||| S:11749 E:11753 ||| DT
coding  ||| S:11753 E:11760 ||| JJ
region  ||| S:11760 E:11767 ||| NN
or  ||| S:11767 E:11778 ||| CC
mutations  ||| S:11778 E:11788 ||| JJ
encoding  ||| S:11788 E:11797 ||| JJ
termination  ||| S:11797 E:11809 ||| NN
codons  ||| S:11809 E:11816 ||| NNS
were  ||| S:11816 E:11821 ||| VBD
discarded ||| S:11821 E:11830 ||| VBN
.  ||| S:11830 E:11840 ||| .
The  ||| S:11840 E:11844 ||| DT
list  ||| S:11844 E:11849 ||| NN
of  ||| S:11849 E:11852 ||| IN
genes  ||| S:11852 E:11858 ||| NNS
was  ||| S:11858 E:11862 ||| VBD
then  ||| S:11862 E:11867 ||| RB
sorted  ||| S:11867 E:11874 ||| VBN
by  ||| S:11874 E:11877 ||| IN
average  ||| S:11877 E:11885 ||| JJ
negative  ||| S:11885 E:11902 ||| JJ
entropy  ||| S:11902 E:11910 ||| NN
of  ||| S:11910 E:11913 ||| IN
the  ||| S:11913 E:11917 ||| DT
mutations ||| S:11917 E:11926 ||| NN
.  ||| S:11926 E:11928 ||| .
We  ||| S:11928 E:11931 ||| PRP
then  ||| S:11931 E:11936 ||| RB
calculated  ||| S:11936 E:11947 ||| VBN
the  ||| S:11947 E:11959 ||| DT
conservation  ||| S:11959 E:11972 ||| NN
entropy ||| S:11972 E:11979 ||| NN
,  ||| S:11979 E:11981 ||| ,
CE ||| S:11981 E:11983 ||| NNP
,  ||| S:11983 E:11985 ||| ,
using ||| S:11985 E:11990 ||| VBG
:  ||| S:11990 E:12000 ||| :
CE  ||| S:12000 E:12003 ||| NNP
=  ||| S:12003 E:12005 ||| SYM
average  ||| S:12005 E:12013 ||| JJ
NE  ||| S:12013 E:12016 ||| NN
of  ||| S:12016 E:12019 ||| IN
mutation  ||| S:12019 E:12028 ||| JJ
positions ||| S:12028 E:12037 ||| NNS
/ ||| S:12037 E:12038 ||| VBP
average  ||| S:12038 E:12046 ||| JJ
NE  ||| S:12046 E:12049 ||| NN
of  ||| S:12049 E:12052 ||| IN
all  ||| S:12052 E:12064 ||| DT
positions  ||| S:12064 E:12074 ||| NNS
in  ||| S:12074 E:12077 ||| IN
the  ||| S:12077 E:12081 ||| DT
gene  ||| S:12081 E:12086 ||| NN
sequence  ||| S:12086 E:12110 ||| FW
